SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 140 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $271,729 | -3.0% | 2,097 | -17.1% | 0.02% | -5.6% |
| Q3 2022 | $280,000 | +27.9% | 2,529 | +96.5% | 0.02% | +125.0% |
| Q4 2020 | $219,000 | +21.0% | 1,287 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $181,000 | -13.8% | 1,287 | -1.6% | 0.01% | -20.0% |
| Q2 2020 | $210,000 | -7.9% | 1,308 | -26.0% | 0.01% | +11.1% |
| Q4 2019 | $228,000 | -95.3% | 1,767 | -95.7% | 0.01% | -95.4% |
| Q1 2019 | $4,868,000 | -20.8% | 40,842 | -27.4% | 0.20% | -32.1% |
| Q4 2018 | $6,143,000 | -82.4% | 56,292 | -73.9% | 0.29% | -75.6% |
| Q3 2018 | $34,869,000 | +8.1% | 215,894 | -11.5% | 1.18% | +0.9% |
| Q2 2018 | $32,250,000 | +33.2% | 243,985 | -25.3% | 1.17% | +23.1% |
| Q1 2018 | $24,208,000 | -38.0% | 326,742 | -53.4% | 0.95% | -38.8% |
| Q4 2017 | $39,016,000 | +20.0% | 701,228 | -2.2% | 1.55% | +14.5% |
| Q3 2017 | $32,513,000 | +42.2% | 716,772 | +5.7% | 1.36% | +35.9% |
| Q2 2017 | $22,864,000 | +27.8% | 678,270 | +12.2% | 1.00% | +21.9% |
| Q1 2017 | $17,892,000 | +62.1% | 604,467 | +50.2% | 0.82% | +55.5% |
| Q4 2016 | $11,041,000 | -32.5% | 402,525 | +51.2% | 0.53% | -36.8% |
| Q3 2016 | $16,353,000 | +247.1% | 266,295 | +7.8% | 0.83% | +215.2% |
| Q2 2016 | $4,712,000 | -54.6% | 247,086 | -23.5% | 0.26% | -61.1% |
| Q3 2015 | $10,371,000 | +29.3% | 322,970 | +22.6% | 0.68% | +9.5% |
| Q2 2015 | $8,019,000 | +74.6% | 263,520 | +21.1% | 0.62% | +40.9% |
| Q3 2014 | $4,593,000 | -31.0% | 217,693 | -2.6% | 0.44% | -28.1% |
| Q2 2014 | $6,656,000 | +52.3% | 223,433 | +22.9% | 0.61% | +46.4% |
| Q1 2014 | $4,370,000 | -55.1% | 181,854 | -57.9% | 0.42% | -28.1% |
| Q4 2013 | $9,727,000 | -42.4% | 432,418 | +20.9% | 0.58% | -50.2% |
| Q3 2013 | $16,892,000 | +149.4% | 357,668 | +100.9% | 1.17% | +1.7% |
| Q2 2013 | $6,772,000 | – | 178,034 | – | 1.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |